Results 141 to 150 of about 43,444 (242)

Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders. [PDF]

open access: yesBrain Commun
Fernandes Gomes B   +9 more
europepmc   +1 more source

Salivary Extracellular Vesicles: Paradigm Shift in Liquid Biopsy Diagnostics

open access: yesJournal of Extracellular Biology, Volume 5, Issue 7, July 2026.
ABSTRACT Extracellular vesicles (EVs), lipid bilayer nanoparticles released by virtually all cells, serve as essential messengers for intercellular communication. Due to their involvement in several pathophysiological processes, EVs have recently gained considerable attention as potentially diagnostic and prognostic biomarkers for various illnesses ...
Kwanele Xulu   +3 more
wiley   +1 more source

Integrating tele-palliative care for atypical Parkinsonian disorders: Lessons learned from a pilot program. [PDF]

open access: yesClin Park Relat Disord
Afshari M   +7 more
europepmc   +1 more source

Does Resistance Training Improve the Quality of Life of People With Parkinson's Disease? Evidence and Recommendations for Clinical Application Through a Systematic Review and Meta‐Analysis of Randomized Clinical Trials

open access: yesPhysiotherapy Research International, Volume 31, Issue 3, July 2026.
ABSTRACT Background Parkinson's disease is a neurological condition with motor and non‐motor symptoms that negatively affect well‐being and quality of life. Objective This review aimed to analyze the effects of resistance training on quality of life in individuals with Parkinson's disease and to summarize recommendations for clinical application.
Loiane Cristina de Souza   +5 more
wiley   +1 more source

Engineering Extracellular Vesicles for Anti‐Aging Therapy: Mechanisms, Applications, and Perspectives

open access: yesAging Cell, Volume 25, Issue 7, July 2026.
This review systematically elucidates the multifactorial anti‐aging mechanisms of extracellular vesicles (EVs). By bridging fundamental biology with advanced bioengineering, scalable manufacturing, and clinical translation, it establishes a comprehensive framework for developing next‐generation EVs‐based precision nanotherapeutics to combat systemic ...
Xian Huang   +6 more
wiley   +1 more source

A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement. [PDF]

open access: yesNeurol Clin Pract
Bruno MK   +17 more
europepmc   +1 more source

The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 1, July 2026.
ABSTRACT Dopaminergic medication used in disorders like Parkinson's disease (PD) and restless legs syndrome can cause impulsive‐compulsive behaviour (ICB), often with strong negative effects on patients' quality of life. This narrative review presents translational evidence on iatrogenic ICB, taking findings from epidemiological, clinical, neuroimaging
Mirjam Wolfschlag   +7 more
wiley   +1 more source

The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 13, Page 3815-3828, July 2026.
Abstract Background and Purpose Cardiovascular diseases are among the most common health problems worldwide. Inflammation plays a critical role in the pathogenesis of various heart diseases. Lipopolysaccharides (LPS) trigger inflammatory mechanisms, leading to an inflammatory response.
Ilter Ilhan   +5 more
wiley   +1 more source

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. [PDF]

open access: yesMov Disord, 2020
Takeshige-Amano H   +17 more
europepmc   +1 more source

Narrative Review of Catatonia in Psychosis and Eating Disorders: Common Intersections and Treatment Considerations

open access: yesEarly Intervention in Psychiatry, Volume 20, Issue 7, July 2026.
ABSTRACT Background Eating disorders (ED) and psychosis/psychotic‐spectrum disorders (PSD) have overlapping symptoms and may co‐occur in a variety of presentations. Due to its debilitating and life‐threatening risk, it is important for clinicians to be aware of how catatonia may present within these co‐occurrences.
Rosiel Elwyn
wiley   +1 more source

Home - About - Disclaimer - Privacy